4Lux MP, Wockel A, Benedict A, et al. Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early- stage breast cancer - a health-economic analysis based on the 100- month analysis of the ATAC trial and the German health system[J]. Onkologie, 2010, 33 (4): 155-166.
5Guth U, Ella WA, Olaitan A, et al. Total vaginal necrosis: a representative example of underreporting severe late toxic reaction after concomitant chemoradiation for cervical cancer [J]. Int J Gynecol Cancer, 2010, 20 (1): 54-60.
6Kaufman B, Wu Y, Amonkar MM, et al. Impaet of lapatinib monotherapy on QOL and pain symptoms in patients with HER2 + relapsed or refractory inflammatory breast cancer [J]. Curr Med Res Opin, 2010, 26 (5): 1065-1073.
7Ostacoli L, Saini A, Ferini-Strambi L, et al. Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy[J]. Qual Life Res, 2010, 19 (4): 531-537.
8Hopwood P, Haviland JS, Sumo G, et al. Comparison of patient- reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: S-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials [J]. Lancet Oncol, 2010, 11(3): 231-240.
9Laky B,Janda M,Kondalsamy-Chennakesavan S,et al.Pretreatment malnutrition and quality of lifeassociation with prolonged length of hospital stay among patients with gynecological cancera cohort study[J].BMC Cancer,2010,10(2):232.
10Jedel E,Waern M,GustafsonD,et al.Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index[J].Hum Reprod,2010,25(2):450-456.
